IS7883A - Bakteríueyðandi indólón oxasólidínón, milliefni til framleiðslu þeirra og lyfjasametningar sem innihalda þau - Google Patents
Bakteríueyðandi indólón oxasólidínón, milliefni til framleiðslu þeirra og lyfjasametningar sem innihalda þauInfo
- Publication number
- IS7883A IS7883A IS7883A IS7883A IS7883A IS 7883 A IS7883 A IS 7883A IS 7883 A IS7883 A IS 7883A IS 7883 A IS7883 A IS 7883A IS 7883 A IS7883 A IS 7883A
- Authority
- IS
- Iceland
- Prior art keywords
- indolone
- oxazolidinone
- bactericidal
- intermediates
- pharmaceutical compositions
- Prior art date
Links
- 230000000844 anti-bacterial effect Effects 0.000 title 1
- QSOIEACKWAXLAR-UHFFFAOYSA-N indol-2-one 1,3-oxazolidin-2-one Chemical compound O=C1NCCO1.C1=CC=CC2=NC(=O)C=C21 QSOIEACKWAXLAR-UHFFFAOYSA-N 0.000 title 1
- 239000000543 intermediate Substances 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/32—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Communicable Diseases (AREA)
- Animal Behavior & Ethology (AREA)
- Oncology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Plural Heterocyclic Compounds (AREA)
- Indole Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US44973403P | 2003-02-24 | 2003-02-24 | |
| PCT/IB2004/000466 WO2004074282A1 (en) | 2003-02-24 | 2004-02-12 | Antibacterial indolone oxazolidinones, intermediates for their preparation and pharmaceutical compositions containing them |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IS7883A true IS7883A (is) | 2005-06-09 |
Family
ID=32908714
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IS7883A IS7883A (is) | 2003-02-24 | 2005-06-09 | Bakteríueyðandi indólón oxasólidínón, milliefni til framleiðslu þeirra og lyfjasametningar sem innihalda þau |
Country Status (27)
| Country | Link |
|---|---|
| US (1) | US7012088B2 (is) |
| EP (1) | EP1599470A1 (is) |
| JP (1) | JP3887396B2 (is) |
| KR (1) | KR100701226B1 (is) |
| CN (1) | CN100349892C (is) |
| AP (1) | AP2005003375A0 (is) |
| AU (1) | AU2004213246A1 (is) |
| BR (1) | BRPI0406824A (is) |
| CA (1) | CA2515984A1 (is) |
| CO (1) | CO5601039A2 (is) |
| CR (1) | CR7956A (is) |
| EA (1) | EA009725B1 (is) |
| EC (1) | ECSP055980A (is) |
| GE (1) | GEP20084306B (is) |
| HK (1) | HK1082253A1 (is) |
| HR (1) | HRP20050658A2 (is) |
| IS (1) | IS7883A (is) |
| MA (1) | MA27661A1 (is) |
| MX (1) | MXPA05008960A (is) |
| NO (1) | NO20052794L (is) |
| OA (1) | OA13032A (is) |
| PL (1) | PL377428A1 (is) |
| RS (1) | RS20050649A (is) |
| TN (1) | TNSN05202A1 (is) |
| UA (1) | UA80326C2 (is) |
| WO (1) | WO2004074282A1 (is) |
| ZA (1) | ZA200505225B (is) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7141588B2 (en) * | 2002-02-25 | 2006-11-28 | Pfizer, Inc. | N-aryl-2-oxazolidinone-5-carboxamides and their derivatives |
| EP1781642A1 (en) * | 2004-08-06 | 2007-05-09 | Pharmacia & Upjohn Company LLC | Oxazolidinones containing oxindoles as antibacterial agents |
| AU2006231919A1 (en) * | 2005-04-06 | 2006-10-12 | Pharmacia & Upjohn Company Llc | 7-fluoro-1,3-dihydro-indol-2-one oxazolidinones as antibacterial agents |
| AU2006231918A1 (en) * | 2005-04-06 | 2006-10-12 | Pharmacia & Upjohn Company Llc | An oxindole oxazolidinone as antibacterial agent |
| KR20080023680A (ko) | 2005-05-10 | 2008-03-14 | 인터뮨, 인크. | 스트레스-활성화 단백질 키나제 시스템을 조절하기 위한피리돈 유도체 |
| WO2007088478A1 (en) * | 2006-02-01 | 2007-08-09 | Pfizer Products Inc. | Indazole oxazolidinones as antibacterial agents |
| JP2009526036A (ja) * | 2006-02-08 | 2009-07-16 | ファイザー・プロダクツ・インク | 抗菌剤としてのオキシインドールを含有するオキサゾリジノン |
| MX2010012848A (es) | 2008-06-03 | 2011-03-01 | Intermune Inc | Compuestos y metodos para tratar trastornos inflamatorios y fibroticos. |
| FR2948940B1 (fr) * | 2009-08-04 | 2011-07-22 | Servier Lab | Nouveaux derives dihydroindolones, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| JP5685384B2 (ja) * | 2010-03-29 | 2015-03-18 | 公益財団法人相模中央化学研究所 | ３，３−ジフルオロ−２，３−ジヒドロインドール−２−オン誘導体の製造方法 |
| AR092742A1 (es) | 2012-10-02 | 2015-04-29 | Intermune Inc | Piridinonas antifibroticas |
| HUE034106T2 (en) * | 2012-10-17 | 2018-01-29 | Univ Okayama | Compound, tautomer and geometric isomer thereof, compound, tautomer or salt of geometric isomer, process for preparing the compound, tautomer, isomer or salt, antimicrobial agent and anti-infectious drug |
| CN103193794B (zh) * | 2013-04-12 | 2016-04-06 | 中国药科大学 | 一种异吲哚酮并异噁唑类稠环化合物及其合成方法 |
| CN106459042B (zh) | 2014-04-02 | 2019-06-28 | 英特穆恩公司 | 抗纤维化吡啶酮类 |
| CN107151225B (zh) * | 2017-06-30 | 2020-05-08 | 贵州大学 | 2-羟基吲哚类衍生物、其制备方法和用途 |
| CN113773306B (zh) * | 2021-10-29 | 2023-11-10 | 四川农业大学 | 3,3-二取代吲哚酮类化合物及其制备方法和应用 |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5225565A (en) * | 1988-09-15 | 1993-07-06 | The Upjohn Company | Antibacterial 3-(fused-ring substituted)phenyl-5β-amidomethyloxazolidin-2-ones |
| WO1990002744A1 (en) | 1988-09-15 | 1990-03-22 | The Upjohn Company | In position 3 substituted-5-beta-amidomethyl-oxazolidin-2-ones |
| US5164510A (en) * | 1988-09-15 | 1992-11-17 | The Upjohn Company | 5'Indolinyl-5β-amidomethyloxazolidin-2-ones |
| MY115155A (en) | 1993-09-09 | 2003-04-30 | Upjohn Co | Substituted oxazine and thiazine oxazolidinone antimicrobials. |
| DE19514313A1 (de) * | 1994-08-03 | 1996-02-08 | Bayer Ag | Benzoxazolyl- und Benzothiazolyloxazolidinone |
| HRP960159A2 (en) * | 1995-04-21 | 1997-08-31 | Bayer Ag | Benzocyclopentane oxazolidinones containing heteroatoms |
| DE19601627A1 (de) * | 1996-01-18 | 1997-07-24 | Bayer Ag | Heteroatomhaltige Cyclopentanopyridyl-Oxazolidinone |
| DE19604223A1 (de) * | 1996-02-06 | 1997-08-07 | Bayer Ag | Neue substituierte Oxazolidinone |
| DE19805117A1 (de) | 1998-02-09 | 1999-08-12 | Bayer Ag | Neue Oxazolidinone mit azolhaltigen Tricyclen |
| GB9812019D0 (en) | 1998-06-05 | 1998-07-29 | Zeneca Ltd | Chemical compounds |
| KR20010052615A (ko) | 1998-06-05 | 2001-06-25 | 다비드 에 질레스 | 옥사졸리디논 유도체, 이것의 제조 방법 및 이것을함유하는 약학 조성물 |
| GB9821938D0 (en) | 1998-10-09 | 1998-12-02 | Zeneca Ltd | Chemical compounds |
| AU1045300A (en) | 1998-11-17 | 2000-06-05 | Bayer Aktiengesellschaft | Novel heterocyclyl-substituted oxazolidone derivatives |
| DE19962924A1 (de) | 1999-12-24 | 2001-07-05 | Bayer Ag | Substituierte Oxazolidinone und ihre Verwendung |
| PE20011124A1 (es) | 2000-03-31 | 2001-10-28 | Upjohn Co | Nuevos agentes antibacterianos de benzosultam oxazolidinona |
| GB0009803D0 (en) | 2000-04-25 | 2000-06-07 | Astrazeneca Ab | Chemical compounds |
| US8048386B2 (en) | 2002-02-25 | 2011-11-01 | Cepheid | Fluid processing and control |
| PE20030044A1 (es) | 2000-11-17 | 2003-02-09 | Upjohn Co | Isoxazolinonas biciclicas de formula i |
| EP1443930A1 (en) | 2001-10-25 | 2004-08-11 | AstraZeneca AB | Isoxazoline derivatives useful as antimicrobials |
-
2004
- 2004-01-22 US US10/762,838 patent/US7012088B2/en not_active Expired - Fee Related
- 2004-02-12 EA EA200501341A patent/EA009725B1/ru not_active IP Right Cessation
- 2004-02-12 CN CNB2004800027371A patent/CN100349892C/zh not_active Expired - Fee Related
- 2004-02-12 BR BR0406824-6A patent/BRPI0406824A/pt not_active IP Right Cessation
- 2004-02-12 RS YUP-2005/0649A patent/RS20050649A/sr unknown
- 2004-02-12 EP EP04710451A patent/EP1599470A1/en not_active Withdrawn
- 2004-02-12 KR KR1020057015556A patent/KR100701226B1/ko not_active IP Right Cessation
- 2004-02-12 AP AP2005003375A patent/AP2005003375A0/xx unknown
- 2004-02-12 GE GEAP20048948A patent/GEP20084306B/en unknown
- 2004-02-12 OA OA1200500233A patent/OA13032A/en unknown
- 2004-02-12 JP JP2005518544A patent/JP3887396B2/ja not_active Expired - Fee Related
- 2004-02-12 MX MXPA05008960A patent/MXPA05008960A/es active IP Right Grant
- 2004-02-12 PL PL377428A patent/PL377428A1/pl not_active Application Discontinuation
- 2004-02-12 AU AU2004213246A patent/AU2004213246A1/en not_active Abandoned
- 2004-02-12 WO PCT/IB2004/000466 patent/WO2004074282A1/en active Application Filing
- 2004-02-12 CA CA002515984A patent/CA2515984A1/en not_active Abandoned
- 2004-12-02 UA UAA200509025A patent/UA80326C2/uk unknown
-
2005
- 2005-06-09 IS IS7883A patent/IS7883A/is unknown
- 2005-06-09 NO NO20052794A patent/NO20052794L/no not_active Application Discontinuation
- 2005-06-28 ZA ZA200505225A patent/ZA200505225B/en unknown
- 2005-07-19 HR HR20050658A patent/HRP20050658A2/hr not_active Application Discontinuation
- 2005-08-19 CO CO05082195A patent/CO5601039A2/es not_active Application Discontinuation
- 2005-08-22 CR CR7956A patent/CR7956A/es unknown
- 2005-08-24 EC EC2005005980A patent/ECSP055980A/es unknown
- 2005-08-24 MA MA28456A patent/MA27661A1/fr unknown
- 2005-08-24 TN TNP2005000202A patent/TNSN05202A1/fr unknown
-
2006
- 2006-04-11 HK HK06104354A patent/HK1082253A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| HK1082253A1 (en) | 2006-06-02 |
| NO20052794L (no) | 2005-11-01 |
| EA200501341A1 (ru) | 2006-02-24 |
| WO2004074282A1 (en) | 2004-09-02 |
| US7012088B2 (en) | 2006-03-14 |
| JP2006515012A (ja) | 2006-05-18 |
| ZA200505225B (en) | 2006-11-29 |
| AP2005003375A0 (en) | 2005-09-30 |
| KR20050102135A (ko) | 2005-10-25 |
| KR100701226B1 (ko) | 2007-03-29 |
| MA27661A1 (fr) | 2005-12-01 |
| CA2515984A1 (en) | 2004-09-02 |
| TNSN05202A1 (fr) | 2007-06-11 |
| RS20050649A (en) | 2007-11-15 |
| NO20052794D0 (no) | 2005-06-09 |
| GEP20084306B (en) | 2008-02-11 |
| BRPI0406824A (pt) | 2005-12-27 |
| AU2004213246A1 (en) | 2004-09-02 |
| CR7956A (es) | 2005-12-01 |
| PL377428A1 (pl) | 2006-02-06 |
| US20040176610A1 (en) | 2004-09-09 |
| CN1742008A (zh) | 2006-03-01 |
| CN100349892C (zh) | 2007-11-21 |
| MXPA05008960A (es) | 2005-11-04 |
| CO5601039A2 (es) | 2006-01-31 |
| ECSP055980A (es) | 2006-01-16 |
| EA009725B1 (ru) | 2008-02-28 |
| HRP20050658A2 (en) | 2005-12-31 |
| UA80326C2 (en) | 2007-09-10 |
| OA13032A (en) | 2006-11-10 |
| EP1599470A1 (en) | 2005-11-30 |
| JP3887396B2 (ja) | 2007-02-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IS7883A (is) | Bakteríueyðandi indólón oxasólidínón, milliefni til framleiðslu þeirra og lyfjasametningar sem innihalda þau | |
| DK1490062T3 (da) | Glukokortikoidmimetika, fremgangsmåder til fremstilling deraf, farmaceutiske sammensætninger og anvendelser deraf | |
| GB0320382D0 (en) | Pharmaceutical compositions | |
| GB0327723D0 (en) | Pharmaceutical compositions | |
| DK1765327T3 (da) | Forbindelser, sammensætninger og fremgangsmåder | |
| PT1467724E (pt) | Composicao farmaceutica orodispersavel de agomelatina | |
| ZA200605080B (en) | Pharmaceutical compositions | |
| DK1587478T3 (da) | Farmaceutisk sammensætning | |
| HU0301154D0 (en) | Pharmaceutical composition | |
| GB0300531D0 (en) | Pharmaceutical compositions | |
| EP1648411A4 (en) | PHARMACEUTICAL COMPOSITIONS | |
| GB0307866D0 (en) | Pharmaceutical composition | |
| EP1699458A4 (en) | PHARMACEUTICAL COMPOSITION | |
| GB0329232D0 (en) | Pharmaceutical composition | |
| GB0317663D0 (en) | Pharmaceutical composition | |
| GB0300885D0 (en) | Pharmaceutical composition | |
| HU0304095D0 (en) | Novel, effective pharmaceutical compositions | |
| GB0306933D0 (en) | Pharmaceutical composition | |
| GB0305579D0 (en) | Pharmaceutical compositions | |
| GB0307869D0 (en) | Pharmaceutical composition | |
| NO20044164L (no) | Farmasoytiske sammensetninger | |
| GB0307862D0 (en) | Pharmaceutical composition | |
| GB0307864D0 (en) | Pharmaceutical composition | |
| GB0307867D0 (en) | Pharmaceutical composition | |
| ITMI20030705A1 (it) | Composizione farmaceutica contenente n-acetil-l-cisteina |